+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Antibiotics Market by Class, Animal Type, End-User, Therapeutic Areas - Global Forecast to 2030- Product Image
Veterinary Antibiotics Market by Class, Animal Type, End-User, Therapeutic Areas - Global Forecast to 2030- Product Image
Sale

Veterinary Antibiotics Market by Class, Animal Type, End-User, Therapeutic Areas - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6021513
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Antibiotics Market grew from USD 2.81 billion in 2024 to USD 3.06 billion in 2025. It is expected to continue growing at a CAGR of 9.04%, reaching USD 4.73 billion by 2030.

Setting the Stage for Insights into Veterinary Antibiotics

The veterinary antibiotics market stands at a pivotal juncture, shaped by evolving animal husbandry practices, shifting regulatory frameworks, and mounting public health concerns. This executive summary provides a concise yet comprehensive overview of the factors driving demand for antimicrobial solutions in both livestock and companion animals, underscoring the critical role of antibiotics in safeguarding animal health and ensuring food safety. As stakeholders seek clarity on emerging trends and strategic directions, this summary distills the most relevant insights to inform decision-making.

Navigating the New Era of Antimicrobial Stewardship

The landscape of veterinary antibiotics has undergone transformative shifts driven by heightened scrutiny around antimicrobial resistance, progressive regulatory mandates, and the rapid evolution of animal care practices. Government authorities worldwide have intensified monitoring and imposed stricter usage guidelines, compelling manufacturers and end-users to adopt more prudent antibiotic stewardship. Simultaneously, the rise of precision livestock farming and digital health platforms has enabled real-time treatment protocols, optimizing therapeutic outcomes while minimizing reliance on broad-spectrum formulations.

Moreover, consumer preferences have steadily gravitated toward products arising from responsible antibiotic use, prompting producers to invest in alternative strategies such as probiotics and vaccines. Technological advances in formulation chemistry and delivery systems have further catalyzed innovation, facilitating sustained release mechanisms that enhance drug efficacy and reduce dosage frequency. In tandem, global supply chain realignments and strategic partnerships are reshaping procurement and distribution models, reinforcing resilience amid geopolitical tensions and evolving trade dynamics.

Assessing the Ripple Effects of US 2025 Tariffs

The introduction of tariffs on key antibiotic precursors and finished products by the United States in early 2025 has had a cumulative impact across the veterinary pharma value chain. These levies have driven up import costs for raw materials sourced from traditional manufacturing hubs, prompting contract manufacturers to reconsider production footprints and to explore nearshoring opportunities. Concurrently, domestic producers have seized the chance to ramp up capacity, positioning themselves as viable alternatives for price-sensitive customers.

The downstream implications include tighter margins for distributors and veterinary clinics, which now face the challenge of balancing higher procurement costs with pressure to maintain affordable treatment tiers for farmers and pet owners. In reaction, several industry players have renegotiated supplier contracts and introduced cost-sharing mechanisms, while others are accelerating research into cost-efficient synthetic routes and targeting local feed-additive applications to mitigate tariff exposure.

Unveiling Demand Drivers Across Key Market Segments

A nuanced comprehension of market segmentation reveals the multifaceted nature of demand, beginning with antibiotic classes. Aminoglycosides such as amikacin and gentamicin continue to anchor treatment portfolios, yet florfenicol from the amphenicol family is distinguishing itself through a favorable safety profile. Within cephalosporins, cefalexin remains a staple for small-animal care, whereas ceftiofur’s broad-spectrum efficacy secures its status in livestock applications. Fluoroquinolones, led by enrofloxacin, are under intensified oversight due to resistance concerns, driving a pivot toward macrolides like tulathromycin, which combine potency with lower resistance risk. The penicillin segment, sustained by amoxicillin, faces competition from newer tetracyclines such as doxycycline that offer enhanced pharmacokinetics.

Differences by animal type underpin usage patterns, with companion animals fueling growth in convenience-dosed injectables and orally administered suspensions, whereas livestock sectors emphasize cost-effective parenteral treatments and feed additives. End-user distinctions further refine demand dynamics: veterinary clinics prioritize high-efficacy, fast-acting formulations; household pet owners seek palatable, easy-to-administer options; and large-scale animal production facilities focus on long-acting compounds that align with herd health protocols. Therapeutic area segmentation sheds light on infection hotspots, where respiratory and soft tissue interventions dominate sales, yet dermatological treatments are gaining prominence as skin infections surge in densely housed livestock.

Dissecting Regional Growth Pathways and Challenges

Regional performance patterns underscore divergent growth trajectories and investment landscapes. The Americas continue to lead in market share, propelled by advanced regulatory frameworks and high adoption of innovative delivery technologies. In contrast, Europe, Middle East & Africa present a complex tapestry of regulations, with the European Union’s stringent antibiotic stewardship measures balanced by emerging economies where access and cost efficiency reign supreme. Meanwhile, Asia-Pacific emerges as a hotspot for both production and consumption, fueled by expanding livestock industries in Southeast Asia and rising pet ownership in urban centers across China and India.

These regional nuances compel suppliers to tailor product portfolios and go-to-market strategies accordingly. In the Americas, premium-priced novel formulations find receptive markets, whereas in EMEA, compliance with evolving regulatory standards is paramount. Companies targeting Asia-Pacific must navigate heterogeneous regulatory landscapes and invest in localized manufacturing or licensing agreements to optimize market entry and sustain long-term growth.

Strategic Moves Shaping the Competitive Arena

Leading players have differentiated themselves through strategic R&D investments, portfolio diversification, and targeted collaborations. Companies with integrated upstream and downstream capabilities have leveraged vertical integration to secure critical raw materials and streamline product development cycles. Partnerships between established pharmaceutical firms and biotech startups are accelerating the pipeline of next-generation antibiotics, focusing on mechanisms that circumvent known resistance pathways.

Equally important are alliances with diagnostic innovators that enable rapid on-farm pathogen identification, empowering veterinarians to prescribe more precise treatments. Market incumbents are expanding their footprints in emerging geographies through joint ventures and licensing agreements, while niche players are carving out specialized offerings in companion animal health. This competitive landscape underscores the imperative for continuous innovation, balanced with robust stewardship programs that align with public health objectives.

Actionable Strategies to Steer Future Growth

Industry leaders must prioritize a multifaceted approach to thrive in the evolving veterinary antibiotics market. First, accelerating investment in precision dosing technologies and diagnostic support tools will enhance treatment accuracy, reduce misuse, and extend product lifecycles. Second, forging strategic alliances with feed additive producers and animal health digital platforms can create integrated solutions that resonate with both livestock operations and companion animal clinics. Third, diversifying supply chains through regional manufacturing hubs and qualified local suppliers will alleviate tariff pressures and safeguard against geopolitical disruptions.

In parallel, companies should champion transparent antibiotic stewardship frameworks, collaborating with regulators, veterinarians, and livestock associations to standardize guidelines that balance therapeutic efficacy with resistance mitigation. Finally, focusing on high-value niche segments-such as dermatological and soft tissue treatments in high-density farming environments-will unlock premium margin opportunities and reinforce leadership in specialized therapeutic areas.

Employing a Rigorous Mixed-Method Research Framework

This research leverages a dual-phase methodology, integrating primary and secondary data collection for a robust analytical foundation. Secondary sources include peer-reviewed journals, regulatory publications, industry white papers, and proprietary databases that provide historical trends, mechanism of action profiles, and regional regulatory updates. Primary research comprises structured interviews with veterinary professionals, animal health executives, and key opinion leaders to validate trends and uncover emerging use cases.

Quantitative analyses were conducted using revenue data, shipment volumes, and prescription databases, while qualitative insights were triangulated to ensure consistency across sources. Rigorous data validation protocols and cross-referencing techniques were employed to minimize bias and uphold accuracy. Throughout the process, continuous engagement with subject matter experts provided real-time feedback, ensuring that findings remain aligned with the latest scientific advancements and market developments.

Synthesizing Insights for Strategic Alignment

In summary, the veterinary antibiotics market is at the confluence of regulatory transformation, technological innovation, and shifting disease dynamics. Stakeholders who understand the interplay between segmentation nuances, regional disparities, and competitive strategies will be best positioned to capture emerging opportunities. As antimicrobial resistance and trade policies continue to influence market trajectories, adopting data-driven approaches and collaborative stewardship initiatives will define the next wave of success.

By synthesizing granular insights on class preferences, end-user behaviors, and regional growth catalysts, this executive summary lays the groundwork for strategic planning. Moving forward, industry participants must remain agile, invest in targeted innovations, and cultivate partnerships that reinforce both profitability and public health imperatives.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Class
    • Aminoglycosides
      • Amikacin
      • Apramycin
      • Gentamicin
      • Kanamycin
      • Neomycin
    • Amphenicols
      • Azidamfenicol
      • Chloramphenicol
      • Florfenicol
      • Metiamycin
      • Thiamphenicol
    • Cephalosporins
      • Cefalexin
      • Cefalonium
      • Cefazolin
      • Cefovecin
      • Ceftiofur
      • Ceftriaxone
    • Fluoroquinolones
      • Ciprofloxacin
      • Danofloxacin
      • Difloxacin
      • Enrofloxacin
      • Norfloxacin
      • Orbifloxacin
    • Macrolides
      • Azithromycin
      • Clarithromycin
      • Erythromycin
      • Gamithromycin
      • Spiramycin
      • Tilmicosin
      • Tulathromycin
      • Tylosin
    • Other Quinolones
      • Cinoxacin
      • Nalidixic Acid
      • Oxolinic Acid
      • Pipemidic Acid
      • Rosoxacin
    • Penicillins
      • Amoxicillin
      • Ampicillin
      • Cloxacillin
      • Oxacillin
      • Penicillin G
      • Penicillin V
    • Polymixins
      • Colistin/Polymyxin E
      • Polymyxin B
    • Sulfonamides
      • Sulfadiazine
      • Sulfamerazine
      • Sulfamethizole
      • Sulfamethoxazole
      • Sulfasalazine
    • Tetracyclines
      • Chlortetracycline
      • Doxycycline
      • Oxytetracycline
      • Tetracycline
    • Trimethoprim
      • Trimethoprim Plus Sulfamethazine
      • Trimethoprim-Sulfadiazine
      • Trimethoprim-Sulfadimidine
      • Trimethoprim-Sulfadoxine
      • Trimethoprim-Sulfamethoxazole (TMP-SMX)
  • Animal Type
    • Companion Animals
      • Cats
      • Dogs
    • Livestock
      • Cattle
      • Poultry
      • Sheep & Goats
      • Swine
  • End-User
    • Animal Production Facilities
    • Household Pet Owners
    • Veterinary Clinics
  • Therapeutic Areas
    • Dermatological Infections
    • Gastrointestinal Infections
    • Reproductive System Infections
    • Respiratory Infections
    • Soft Tissue & Wound Infections
    • Systemic Infections
    • Urinary Tract Infections
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
      • Massachusetts
      • North Carolina
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Ashish Life Science Private Limited
  • Bimeda Inc.
  • Biogénesis Bagó S.A.
  • C.H. Boehringer Sohn AG & Co. KG
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Intas Pharmaceuticals Ltd.
  • Krka, d. d., Novo mesto
  • Kyoritsuseiyaku Corporation
  • LABORATORIO AVI-MEX
  • LABORATORIOS CALIER, S.A.
  • Merck KGaA
  • Neogen Corporation
  • Ourofino Group
  • Sequent Scientific Ltd.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Antibiotics Market, by Class
8.1. Introduction
8.2. Aminoglycosides
8.2.1. Amikacin
8.2.2. Apramycin
8.2.3. Gentamicin
8.2.4. Kanamycin
8.2.5. Neomycin
8.3. Amphenicols
8.3.1. Azidamfenicol
8.3.2. Chloramphenicol
8.3.3. Florfenicol
8.3.4. Metiamycin
8.3.5. Thiamphenicol
8.4. Cephalosporins
8.4.1. Cefalexin
8.4.2. Cefalonium
8.4.3. Cefazolin
8.4.4. Cefovecin
8.4.5. Ceftiofur
8.4.6. Ceftriaxone
8.5. Fluoroquinolones
8.5.1. Ciprofloxacin
8.5.2. Danofloxacin
8.5.3. Difloxacin
8.5.4. Enrofloxacin
8.5.5. Norfloxacin
8.5.6. Orbifloxacin
8.6. Macrolides
8.6.1. Azithromycin
8.6.2. Clarithromycin
8.6.3. Erythromycin
8.6.4. Gamithromycin
8.6.5. Spiramycin
8.6.6. Tilmicosin
8.6.7. Tulathromycin
8.6.8. Tylosin
8.7. Other Quinolones
8.7.1. Cinoxacin
8.7.2. Nalidixic Acid
8.7.3. Oxolinic Acid
8.7.4. Pipemidic Acid
8.7.5. Rosoxacin
8.8. Penicillins
8.8.1. Amoxicillin
8.8.2. Ampicillin
8.8.3. Cloxacillin
8.8.4. Oxacillin
8.8.5. Penicillin G
8.8.6. Penicillin V
8.9. Polymixins
8.9.1. Colistin/Polymyxin E
8.9.2. Polymyxin B
8.10. Sulfonamides
8.10.1. Sulfadiazine
8.10.2. Sulfamerazine
8.10.3. Sulfamethizole
8.10.4. Sulfamethoxazole
8.10.5. Sulfasalazine
8.11. Tetracyclines
8.11.1. Chlortetracycline
8.11.2. Doxycycline
8.11.3. Oxytetracycline
8.11.4. Tetracycline
8.12. Trimethoprim
8.12.1. Trimethoprim Plus Sulfamethazine
8.12.2. Trimethoprim-Sulfadiazine
8.12.3. Trimethoprim-Sulfadimidine
8.12.4. Trimethoprim-Sulfadoxine
8.12.5. Trimethoprim-Sulfamethoxazole (TMP-SMX)
9. Veterinary Antibiotics Market, by Animal Type
9.1. Introduction
9.2. Companion Animals
9.2.1. Cats
9.2.2. Dogs
9.3. Livestock
9.3.1. Cattle
9.3.2. Poultry
9.3.3. Sheep & Goats
9.3.4. Swine
10. Veterinary Antibiotics Market, by End-User
10.1. Introduction
10.2. Animal Production Facilities
10.3. Household Pet Owners
10.4. Veterinary Clinics
11. Veterinary Antibiotics Market, by Therapeutic Areas
11.1. Introduction
11.2. Dermatological Infections
11.3. Gastrointestinal Infections
11.4. Reproductive System Infections
11.5. Respiratory Infections
11.6. Soft Tissue & Wound Infections
11.7. Systemic Infections
11.8. Urinary Tract Infections
12. Americas Veterinary Antibiotics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Veterinary Antibiotics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Veterinary Antibiotics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ashish Life Science Private Limited
15.3.2. Bimeda Inc.
15.3.3. Biogénesis Bagó S.A.
15.3.4. C.H. Boehringer Sohn AG & Co. KG
15.3.5. Ceva Santé Animale
15.3.6. Dechra Pharmaceuticals PLC
15.3.7. Eco Animal Health Group PLC
15.3.8. Elanco Animal Health Incorporated
15.3.9. Intas Pharmaceuticals Ltd.
15.3.10. Krka, d. d., Novo mesto
15.3.11. Kyoritsuseiyaku Corporation
15.3.12. LABORATORIO AVI-MEX
15.3.13. LABORATORIOS CALIER, S.A.
15.3.14. Merck KGaA
15.3.15. Neogen Corporation
15.3.16. Ourofino Group
15.3.17. Sequent Scientific Ltd.
15.3.18. Vetoquinol SA
15.3.19. Virbac SA
15.3.20. Zoetis Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VETERINARY ANTIBIOTICS MARKET MULTI-CURRENCY
FIGURE 2. VETERINARY ANTIBIOTICS MARKET MULTI-LANGUAGE
FIGURE 3. VETERINARY ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VETERINARY ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VETERINARY ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY APRAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY KANAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AZIDAMFENICOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CHLORAMPHENICOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLORFENICOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY METIAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THIAMPHENICOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFALEXIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFALONIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFAZOLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFOVECIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFTIOFUR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFTRIAXONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CIPROFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DANOFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DIFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ENROFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY NORFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ORBIFLOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLARITHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ERYTHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GAMITHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SPIRAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TILMICOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TULATHROMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CINOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY NALIDIXIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXOLINIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PIPEMIDIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ROSOXACIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLOXACILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXACILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLIN G, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLIN V, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COLISTIN/POLYMYXIN E, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFADIAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMERAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMETHIZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMETHOXAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFASALAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CHLORTETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DOXYCYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM PLUS SULFAMETHAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM-SULFADIAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM-SULFADIMIDINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM-SULFADOXINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM-SULFAMETHOXAZOLE (TMP-SMX), BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL PRODUCTION FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DERMATOLOGICAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REPRODUCTIVE SYSTEM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SOFT TISSUE & WOUND INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SYSTEMIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 145. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 146. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 147. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 148. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 149. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 150. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 151. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 152. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 153. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 154. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 155. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 156. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 157. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 158. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 159. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 160. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 164. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 165. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 167. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 168. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 172. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 173. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 174. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 175. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 177. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 208. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 209. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 210. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 211. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 246. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 248. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 249. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 250. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 251. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 252. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 253. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 254. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 255. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 256. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 257. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 258. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 259. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 260. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 261. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 262. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 263. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. GERMANY VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 265. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 266. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 267. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 268. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 269. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 270. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 271. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 272. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 273. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 274. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 275. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 276. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 277. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 278. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 279. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 280. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. FRANCE VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 282. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 283. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 284. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 285. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 286. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 287. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 288. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 299. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 300. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 301. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 302. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 303. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 304. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 305. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 306. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 307. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 308. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 309. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 310. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 311. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 312. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 313. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 314. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. ITALY VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 316. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 317. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD MILLION)
TABLE 318. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD MILLION)
TABLE 319. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD MILLION)
TABLE 320. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD MILLION)
TABLE 321. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD MILLION)
TABLE 322. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD MILLION)
TABLE 323. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD MILLION)
TABLE 324. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD MILLION)
TABLE 325. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD MILLION)
TABLE 326. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD MILLION)
TABLE 327. SPAIN VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD MILLION)
TABLE 328. SPAIN VETERINARY ANTIBIOTIC

Companies Mentioned

The companies profiled in this Veterinary Antibiotics market report include:
  • Ashish Life Science Private Limited
  • Bimeda Inc.
  • Biogénesis Bagó S.A.
  • C.H. Boehringer Sohn AG & Co. KG
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Intas Pharmaceuticals Ltd.
  • Krka, d. d., Novo mesto
  • Kyoritsuseiyaku Corporation
  • LABORATORIO AVI-MEX
  • LABORATORIOS CALIER, S.A.
  • Merck KGaA
  • Neogen Corporation
  • Ourofino Group
  • Sequent Scientific Ltd.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.06 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.73 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030 - Product Image

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030

  • Report
  • 258 Pages
  • Global
From
Veterinary Antibiotics Market Report 2025 - Product Image

Veterinary Antibiotics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal (Pigs, Cattle), By Drug Class (Tetracyclines, Penicillins), By Dosage Form (Oral Powders, Oral Solutions), By Country (UK, Germany), And Segment Forecasts, 2025 - 2030 - Product Image

Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal (Pigs, Cattle), By Drug Class (Tetracyclines, Penicillins), By Dosage Form (Oral Powders, Oral Solutions), By Country (UK, Germany), And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Europe
From
Animal Antibiotics and Antimicrobials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Animal Antibiotics and Antimicrobials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Animal Antibiotics and Antimicrobials - Global Strategic Business Report - Product Image

Animal Antibiotics and Antimicrobials - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From

About the Veterinary Antibiotics Market

The Veterinary Antibiotics market is a segment of the Animal Healthcare/Veterinary industry that focuses on the production and distribution of antibiotics for use in animals. Veterinary antibiotics are used to treat a variety of bacterial infections in animals, including respiratory, gastrointestinal, and urinary tract infections. They are also used to prevent and control the spread of infectious diseases in animals. Veterinary antibiotics are available in a variety of forms, including tablets, capsules, liquids, and injectables. Veterinary antibiotics are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. Veterinary antibiotics are typically prescribed by veterinarians and dispensed by pharmacies. In some cases, they may be available over-the-counter. Some companies in the Veterinary Antibiotics market include Bayer, Merck, Zoetis, Elanco, and Boehringer Ingelheim. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.